Colchicine and risk of hospitalization due to COVID‐19: A population‐based study

Colchicine is one of the most widely studied and best‐known anti‐inflammatory treatments. This study aimed to assess the effect of colchicine on risk of hospitalization due to COVID‐19; and its effect on susceptibility to and severity of the virus in patients with COVID‐19. We carried out a populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sáenz‐Aldea, María, Salgado‐Barreira, Ángel, Taracido Trunk, Margarita, Piñeiro‐Lamas, María, Herdeiro, Maria T., Portela‐Romero, Manuel, Saez, Marc, Figueiras, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107154/
https://www.ncbi.nlm.nih.gov/pubmed/36639903
http://dx.doi.org/10.1002/jmv.28496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107154/
https://www.ncbi.nlm.nih.gov/pubmed/36639903
http://dx.doi.org/10.1002/jmv.28496

Ejemplares similares